China Companion Animal Health Market worth US$ 1.42 Bn 2024 with a CAGR of 6.4%
The report "China Companion Animal Health Market, By Products (Therapeutics (Vaccines, Parasiticides, Anti-Infectives, Medicinal Feed Additives, and Other Therapeutics) and Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, and Other Diagnostics)), By Animal Type (Dogs & Cats, Horses, and Other Companion Animals) - Trends, Analysis and Forecast till 2030”. China Commercial Real Estate is projected to grow from US$ 0.86 Bn in 2019 to US$ 1.42 Bn in 2024 with a CAGR of 6.4%. The rising popularity of pet ownership in China is the major driver for the target market growth in the country. Also, the introduction of healthcare innovations converging with different therapeutic indications has upsurge the target market growth in China. Furthermore, increasing awareness among the pet owners of their pet's health and nutrition has augmented the target market growth in China. Moreover, pet owners are seeking a veterinary service which has in turn, has created a growing demand for diversified forms of companion animal healthcare products. This factor has propelled China's target market. Additionally, various products of health diseases developed in animals have increased the demand for vaccines and diagnostic tests. This has fueled the country's target market owing to the need to treat and cure the variety of diseases associated with the health of cats and dogs.
Key Highlights:
• In July 2018, Merck & Co. got approval from the European Commission to market its Ebola vaccine.
To know the upcoming trends and insights prevalent in this market, click the link below:
Links: https://prophecymarketinsights.com/market_insight/China-Companion-A...

Key Market Insights from the report:
The China companion animal health market accounted for US$ 0.86 billion in 2019 and is projected to register a moderate CAGR of 6.4% over the forecast period. The market report has been segmented based on the property type.
• Based on the product, the China companion animal health market is segmented into therapeutics and diagnostics. Therapeutics is further sub-segmented into vaccines, parasiticides, anti-infectives, medicinal feed additives, and other therapeutics. Whereas, diagnostics is sub-segmented into immunodiagnostic tests, molecular diagnostics, diagnostic imaging, and other diagnostics.
• Based on animal type, the target market is segmented into dogs & cats, horses, and other companion animals.
Related reports :
1) Global Animal Parasiticides Market - Trends, Analysis, and Forecast till 2029
2) Global Animal Diagnostics Market - Trends, Analysis, and Forecast till 2029
3) Global Animal Medicine Market - Trends, Analysis, and Forecast till 2029
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “China Commercial Real Estate Market”, China Companion Animal Health Market, By Products (Therapeutics (Vaccines, Parasiticides, Anti-Infectives, Medicinal Feed Additives, and Other Therapeutics) and Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, and Other Diagnostics)), By Animal Type (Dogs & Cats, Horses, and Other Companion Animals) - Trends, Analysis and Forecast till 2030
The prominent player operating in the Australia Plastic Packaging market includes Bayer AG, Elanco Animal Health, Merck & Co., Virbac, and Zoetis Inc.

Contact Us:
Sales
Prophecy Market Insights
Email- [email protected]